An Uninformative Truth: The Logic of Amarin's Off-Label Promotion.

Abstract

Spencer Phillips Hey and Aaron Kesselheim propose that informativeness-asserting scientific facts-rather than truthfulness ought to be the standard for regulating commercial speech about pharmaceuticals.